| CEO Name | Thierry Bernard |
| Nationality | France |
| Net Worth Estimation | $10 million |
Thierry Bernard's estimated net worth of around $10 million is attributed to his executive compensation, performance-based stock awards, and long-term incentives accrued during his tenure as CEO of Qiagen N.V. Public filings and disclosures reveal his primary assets stem from shares and options connected to the company's market performance.
Thierry Bernard, CEO of Qiagen, has an estimated net worth of $10 million, which is at the minimum range for biotechnology CEOs (minimum: $10M, maximum: $80M). His net worth represents approximately 12.5% of the maximum CEO net worth in this business category.
Business Category: Biotechnology
Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 80000000 USD
Thierry Bernard Performance in Qiagen
Thierry Bernard, CEO of Qiagen, demonstrates strategic leadership by driving innovation and operational excellence in the molecular diagnostics sector. His decision-making focuses on expanding Qiagen's portfolio through acquisitions and digital transformation, strengthening global market presence. Under his leadership, Qiagen has improved financial performance, enhanced R&D capabilities, and solidified its position as a leader in life sciences and diagnostics.
Latest News
Qiagen Reports Strong Q3 2025 Growth and CEO Transition Plan
Qiagen exceeded Q3 2025 sales forecasts with 6% growth and pursued strategic initiatives such as acquiring Parse Biosciences to expand into single-cell technologies. CEO Thierry Bernard announced plans to step down after successor appointment, continuing until the transition is complete, reflecting a leadership change at the company.
Source: http://intellectia.ai/earnings/qiagen-nv-earnings-q3-2025